Voptica is a pioneering brand in the field of optical technologies in ophthalmology. With a focus on personalized surgical outcomes, Voptica has revolutionized the industry with its innovative products and services. One of their flagship products is VAO® - the world's only adaptive optics-based visual simulator device.

This breakthrough technology allows ophthalmic surgeons to accurately simulate visual outcomes before performing surgeries, enhancing precision and improving patient satisfaction. In addition, Voptica offers ArtIOLs®, a range of meniscus-shaped extended depth of focus intraocular lenses. These lenses provide unparalleled peripheral quality, giving patients improved vision and reducing the need for glasses after cataract surgery.

With a track record spanning over a decade, Voptica has achieved significant milestones, including the successful commercialization of VAO®, clinical studies involving over 2000 patients, and the development of the first ArtIOLs design. Supported by a team of experienced professionals and collaborations with esteemed institutions such as the University of Murcia, Voptica continues to push the boundaries of ophthalmic technology, ensuring better visual outcomes for patients worldwide